SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme -- Ignore unavailable to you. Want to Upgrade?


To: Trumptown who wrote (3150)6/7/1998 5:49:00 PM
From: TokyoMex  Read Replies (1) | Respond to of 8798
 
For Better Earnings, Try Bigger Write-Offs

By GRETCHEN MORGENSON

NEW YORK -- While the stock market ended last week on a high note, pleased with the mix of economic reports, one little-noted piece of data had ominous implications for investors.

Corporate write-offs, as a percentage of the reported earnings per share of the Standard & Poor's 500-stock index, surged in the first quarter to 14 percent. Of the $10.25 a share that the S&P 500 companies reported in earnings for the quarter, write-offs totaled $1.44 a share.

This is more than just a blip. Gabrielle Napolitano, vice president for investment research at Goldman, Sachs, has collected such data for 10 years. She says write-offs have never been higher than they are now.

This is unusual given that we are in an economic boom. Some of the write-offs are a result of mergers, in which companies deduct acquisition charges. The Asian crisis is another factor: 35 percent of the first quarter's write-offs related to commercial banks' loan-loss provisions.

But an alarmingly large chunk of the write-offs -- 15.3 percent -- were nonrecurring charges related to the purchase of so-called in-process research and development. That was up 70 percent over last year.

Why alarming? The rise may indicate that increasing numbers of companies are using an arcane accounting rule to artificially bolster their earnings.

Whenever one company acquires another, some of the assets are of little value to the combined companies. That is especially true for technology or pharmaceutical concerns.

Accounting rules allow the acquiring company to write off immediately against earnings the total value of the in-process R&D that its management considers worthless. It is a nonrecurring charge.

Why should this matter to an investor? Because it affects a company's earnings. Since the one-time charge reduces the value of the acquired assets, it also lowers depreciation expense in future years. And depreciation charges shrink earnings.

So when a company takes a one-time write-off for purchased R&D, future earnings look better than they would have had the company depreciated those assets over time. And if the assets turn out to be not so worthless after all, any income they produce drops straight to the bottom line, unimpeded by depreciation expense.

Howard M. Schilit, president of the Center for Financial Research and Analysis in Rockville, Md., notes that these write-offs not only are much more prevalent today, but that they now amount to big money. "We're seeing a lot of companies that put absurd amounts -- even 95 percent of the purchase price of an acquisition -- into in-process R&D write-offs," he said.

Consider the peculiar case of Applied Materials Inc., a formerly high-flying maker of semiconductor equipment. In the quarter ending in January, it paid $32.2 million to a company in a licensing agreement.

Rather than consider the fee an operating expense, as Schilit said would be typical, Applied Materials called it in-process R&D, even though no acquisition had transpired. That accounting improved the company's operating cash flow by 26 percent.

"Companies do more of these things when their business weakens," Schilit said. "If things are humming, they don't need to reach." The company was closed Friday and did not return a phone message seeking comment.

Indeed, in the same quarter, the company's margins fell significantly. In the April quarter, sales dropped 10 percent.

Sunday, June 7, 1998
Copyright 1998 The New York Times



To: Trumptown who wrote (3150)6/7/1998 5:51:00 PM
From: TokyoMex  Read Replies (1) | Respond to of 8798
 
The Other Portfolio Risk: Foundering in a Sea of Illiquidity applies to many ^#%$ pennies as well.

By GRETCHEN MORGENSON

The bull market in stocks has been long and lovely, but even unsophisticated mutual fund investors understand the nature of market risk. If the prices of many stocks in a fund's portfolio drop, fund holders will lose, too.

Understanding a fund's exposure to liquidity risk, however, is quite another matter. Liquidity risk is the possibility that the price of a stock will drop, and therefore may push down the fund's net asset value, when a manager tries to sell a large position. Or that the price will climb, forcing a manager to pay too much when buying a large chunk.

Unless investors have examined a fund's holdings in each stock and compared them with the total shares outstanding in the company, it is tough to fathom such risk for a particular fund.

Although it is not much of a concern in large-cap stock funds, liquidity risk can wreak real havoc in micro-cap funds, which invest in fledgling companies with market values of $250 million or less. Positions in such companies are much harder to get in and out of without roiling the market.

How damaging can illiquid stocks be to a portfolio? Plenty, as shareholders in two Dreyfus small-cap stock funds, Premier Aggressive Growth A, with $264 million in assets, and Aggressive Growth, at $77 million, are finding out.

Indeed, these two funds are textbook examples of the perils of illiquidity. So far this year, through Thursday, shareholders in Premier Aggressive Growth have lost 13.5 percent; those in Aggressive Growth are down 18 percent. As a benchmark, the Wilshire Small-Cap index is up 10.8 percent. Last year, Premier Aggressive Growth was down 13 percent; Aggressive Growth lost almost 16 percent.

Aggressive, yes. Growth, no.

Performance like this may explain the April news that the funds' manager since August 1995, Michael L. Schonberg, was being joined by Paul A. LaRocco, late of Founders Asset Management in Denver, who was named the primary manager. Mellon Bank Corp. owns both the Founders and Dreyfus fund companies.

For the two and a half years that Schonberg ran the fund alone, he bought speculative technology or biotechnology companies with few shares outstanding. He even borrowed money to buy shares.

LaRocco takes a different tack, favoring bigger-name stocks with $1 billion to $5 billion in market value. In an interview, he said he is still running the funds as aggressive-growth vehicles. "But we will broaden the funds' holdings out a little," he said. "Mid-cap stocks are a good place to be here. As earnings growth among large-cap stocks slows, investors will move down the market-cap range."

Dreyfus did not make Schonberg available for an interview last week.

Even if LaRocco is a brilliant stock-picker, the beleaguered Dreyfus fund holders are not likely to recoup their losses any time soon. That is because escaping a portfolio of illiquid stocks is like exiting a crowded theater after somebody has yelled "Fire!"

How illiquid are some of the holdings? Frighteningly so. According to Morningstar Inc., the Chicago financial publisher, the median market capitalization of the larger of the two funds, Premier Aggressive Growth, is a Lilliputian $157 million. Across the micro-cap fund category, only 20 percent of funds have a median market capitalization this small or smaller.

The median market cap of Aggressive Growth is even smaller, at $87 million. Only 10 percent of micro-cap funds in Morningstar's universe have median market values that tiny.

More than 10 percent of Premier Aggressive Growth's assets are in stocks that trade at $5 a share or less. In the Aggressive Growth fund, 20 percent fall in that range.

Another measure of both funds' high risk levels can be found in the concentration of fund holdings. As of April, Premier Aggressive Growth held 70 stocks; each of the top six holdings accounted for between 4 percent and 7 percent of the fund's assets.

Aggressive Growth was even more concentrated, at 54 stocks. Its No. 1 holding, a cosmetics and medical technology concern called Chromatics Color Science International, accounted for almost 13 percent of the fund's assets. That's staggering, given that a top holding in a fund typically accounts for 2 percent to 3 percent of assets.

Dreyfus is making a big bet on Chromatics Color Science, a company that was brought public in 1993 by Investors Associates, a brokerage firm that closed last year after a number of state securities regulators revoked its license. Chromatics Color Science trades around $11.50, down from $17.25 in March. Dreyfus owned 1.5 million shares as of March, more than 10 percent of the company's shares outstanding.

The bet on Chromatics is not the only big gamble fund holders have made. Almost 30 percent of the assets in Premier Aggressive Growth are stocks of obscure companies in which Dreyfus owns more than 5 percent of the shares outstanding. In the Aggressive Growth fund, 67 percent of the assets are stocks of companies in which Dreyfus owns more than 5 percent of shares.

For example, in March, Dreyfus owned 23 percent of Atlantic Pharmaceuticals, a development-stage biotechnology company trading at around $6.25 that has no sales and lost $14 million since 1994.. Dreyfus also owned 16.4 percent of Oncormed Inc., another money-losing biotechnology concern, trading at 75 cents a share. Then there's Advanced Photonix, which says it manufactures "proprietary solid-state large-area avalanche photodiodes." Some 14 percent of the stock, trading at a recent $1, was owned by Dreyfus as of March.

This concentration in illiquid stocks is fine when the fund manager is buying. As the buying wave rises, so does the stock's price. This in turn raises the fund's net asset value, making the bet look smart.

But when the buying dries up, trouble begins. If the stock does not have positive earnings or other good news to support it, the price begins to flag. The bigger the position, the harder it is to get out. Which is precisely the predicament that LaRocco finds himself in at Dreyfus.

Jon Hale, an equity fund analyst at Morningstar who follows Dreyfus funds, said: "This portfolio is not something you can change that quickly. He will rotate as he can out of most of the micro-cap stuff as the market lets him."

LaRocco has two choices. He can unload the positions he inherited en masse and start fresh. Or he can hope that a surge in investor ardor for micro-cap stocks will allow him to sell his positions piecemeal without scorching the market. He has already started to sell some. This may explain why Premier Aggressive Growth is down 13 percent since early April, when LaRocco took over, and Aggressive Growth has lost 15 percent. "The sooner these funds have restructured their portfolios," Hale said, "the better their risk-return profile will be."

Of course, if the funds sell many stocks at a loss, any gains going forward under their new manager may be offset. That is the only silver lining to the liquidity cloud hanging over these mutual funds.

Sunday, June 7, 1998
Copyright 1998 The New York Times



To: Trumptown who wrote (3150)6/7/1998 10:29:00 PM
From: Dave Gore  Respond to of 8798
 
ok